{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:22:28Z","timestamp":1790230948172,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ijantimicag.2017.09.009","type":"journal-article","created":{"date-parts":[[2017,9,14]],"date-time":"2017-09-14T21:32:11Z","timestamp":1505424731000},"page":"140-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["IncA\/C plasmids conferring high azithromycin resistance in vibrio cholerae"],"prefix":"10.1016","volume":"51","author":[{"given":"Ruibai","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haican","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuqin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanglin","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ijantimicag.2017.09.009_bib0010","article-title":"Antimicrobial drugs for treating cholera","author":"Leibovici-Weissman","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijantimicag.2017.09.009_bib0015","first-page":"613","article-title":"In vitro activity of azithromycin (CP-62,993), a novel macrolide, against enteric pathogens","volume":"14","author":"Jones","year":"1988","journal-title":"Drugs Exp Clin Res"},{"key":"10.1016\/j.ijantimicag.2017.09.009_bib0020","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000007101","article-title":"Evaluation of different antibiotics in inhibiting colonization of Vibrio cholerae O1 and O139 in the rabbit intestine","volume":"44","author":"Chakrabarti","year":"1998","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijantimicag.2017.09.009_bib0025","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/S0140-6736(02)11680-1","article-title":"Comparison of single-dose azithromycin and 12-dose, 3-day erythromycin for childhood cholera: a randomised, double-blind trial","volume":"360","author":"Khan","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2017.09.009_bib0030","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1056\/NEJMoa054493","article-title":"Single-dose azithromycin for the treatment of cholera in adults","volume":"354","author":"Saha","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2017.09.009_bib0035","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1651-2227.2003.tb00598.x","article-title":"Azithromycin in the treatment of cholera in children","volume":"92","author":"Bhattacharya","year":"2003","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.ijantimicag.2017.09.009_bib0040","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/BF02000410","article-title":"Azithromycin resistance in Campylobacter jejuni and Campylobacter coli","volume":"12","author":"Rautelin","year":"1993","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.09.009_bib0045","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMoa040216","article-title":"Macrolide resistance in Treponema pallidum in the United States and Ireland","volume":"351","author":"Lukehart","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2017.09.009_bib0050","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1128\/JCM.02392-08","article-title":"Molecular characterization of syphilis in patients in Canada: azithromycin resistance and detection of Treponema pallidum DNA in whole-blood samples versus ulcerative swabs","volume":"47","author":"Martin","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2017.09.009_bib0055","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1086\/498899","article-title":"Azithromycin-resistant syphilis infection: San Francisco, California, 2000\u20132004","volume":"42","author":"Mitchell","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.09.009_bib0060","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/jac\/dkp188","article-title":"Emergence of high-level azithromycin resistance in Neisseria gonorrhoeae in England and Wales","volume":"64","author":"Chisholm","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.09.009_bib0065","doi-asserted-by":"crossref","first-page":"e1933","DOI":"10.1371\/journal.pntd.0001933","article-title":"Azithromycin and ciprofloxacin resistance in Salmonella bloodstream infections in Cambodian adults","volume":"6","author":"Vlieghe","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijantimicag.2017.09.009_bib0070","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4103\/0301-4738.99974","article-title":"Azithromycin, fluoroquinolone and chloramphenicol resistance of non-chlamydia conjunctival bacteria in rural community of Ethiopia","volume":"62","author":"Abera","year":"2014","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.ijantimicag.2017.09.009_bib0075","doi-asserted-by":"crossref","first-page":"900","DOI":"10.3855\/jidc.3003","article-title":"Etiological diversity of diarrhoeal disease in Bangladesh","volume":"7","author":"Das","year":"2013","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.ijantimicag.2017.09.009_bib0080","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/tmi.12231","article-title":"Changing patient population in Dhaka Hospital and Matlab Hospital of icddr,b","volume":"19","author":"Das","year":"2014","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.ijantimicag.2017.09.009_bib0085","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1099\/jmm.0.034744-0","article-title":"Multi-drug resistant Vibrio cholerae O1 variant El Tor isolated in northern Vietnam between 2007 and 2010","volume":"61","author":"Tran","year":"2012","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2017.09.009_bib0090","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ijantimicag.2012.06.010","article-title":"Antibiotic resistance of Vibrio cholerae O1 El Tor strains from the seventh pandemic in China, 1961\u20132010","volume":"40","author":"Wang","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2017.09.009_bib0095","article-title":"Multiple antibiotic resistance of Vibrio cholerae serogroup O139 in China from 1993 to 2009","volume":"7","author":"Yu","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijantimicag.2017.09.009_bib0100","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0924-8579(03)00039-6","article-title":"Mutations causing in vitro resistance to azithromycin in Neisseria gonorrhoeae","volume":"21","author":"Johnson","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2017.09.009_bib0105","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3389\/fmicb.2012.00384","article-title":"Erratum: acquired antibiotic resistance genes: an overview","volume":"3","author":"Roberts","year":"2012","journal-title":"Front Microbiol"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917303497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917303497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T17:34:32Z","timestamp":1535391272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857917303497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0924857917303497"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.09.009","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IncA\/C plasmids conferring high azithromycin resistance in vibrio cholerae","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}